Cart
sales@molnova.com
Home - Products - Endocrinology/Hormones - Aromatase - Finrozole

Finrozole

CAS No. 160146-17-8

Finrozole( —— )

Catalog No. M34254 CAS No. 160146-17-8

Finrozole (MPV 2213ad) is a novel selective aromatase inhibitor that is partially reversible for breast development.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 304 In Stock
10MG 456 In Stock
25MG 747 In Stock
50MG 1004 In Stock
100MG 1376 In Stock
200MG Get Quote In Stock
500MG 2753 In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    Finrozole
  • Note
    Research use only, not for human use.
  • Brief Description
    Finrozole (MPV 2213ad) is a novel selective aromatase inhibitor that is partially reversible for breast development.
  • Description
    Finrozole (MPV-2213ad) is a nonsteroidal, orally active and competitive aromatase enzyme inhibitor. Finrozole can be used for urinary symptoms research.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    Aromatase
  • Recptor
    Aromatase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    160146-17-8
  • Formula Weight
    322.34
  • Molecular Formula
    C18H15FN4O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    [C@H]([C@H](CC1=CC=C(F)C=C1)O)(C2=CC=C(C#N)C=C2)N3C=NC=N3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. O Ahokoski, et al. Pharmacokinetics of finrozole (MPV-2213ad), a novel selective aromatase inhibitor, in healthy men. Br J Clin Pharmacol. 2001 Dec;52(6):702-4.?
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Minamestane

    Minamestane is a novel irreversible aromatase inhibitor.Minamestane induces time-dependent inhibition of human placental aromatase with a half-life of 4 minutes and a K of 59 nM.Minamestane has antitumor activity.

  • Exemestane

    Exemestane is an oral steroidal aromatase inhibitor used in the adjuvant treatment of hormonally-responsive (also called hormone-receptor-positive, estrogen-responsive) breast Y in postmenopausal women.

  • Testolactone

    Testolactone is an aromatase inhibitor, blocks conversion of androgens to estrogens.It is progesterone derivative with antineoplastic activity.?

Sign In Join Free